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General Procedures. UV spectra were recorded on a Shimadzu UV-1601 UV-VIS spectrophotometer. IR spectra were obtained on a Perkin Elmer Spectrum 1000 FT-IR Spectrometer. 1 H and 2D NMR spectral data were recorded at 600 MHz in DMSO-d 6 solution on Varian System spectrometer, and chemical shifts were referenced to the corresponding residual solvent signal. 13 C NMR spectra were acquired at 100 MHz on a Varian System spectrometer. High resolution ESI-TOF mass spectra were provided by The Scripps Research Institute, La Jolla, CA. Low resolution LC/ESI-MS data were measured using an Agilent 1200 series LC/MS system with a reversed-phase C18 column (Phenomenex Luna, 150 mm × 4.6 mm, 5 µm) at a flow rate of 0.7 mL/min.
Preparative HPLC was performed on an Agilent 1200 series instrument with a DAD detector, using a PhenylHexyl column (Phenomenex Luna, 250×10.0 mm, 5 µm). ODS (50 µm, Merck) and Sephadex LH-20 (GE Healthcare) were used for column chromatography. Quinone reductase-2 (QR2) was purchased from Abcam.
Collection and phylogenetic analysis of strain SNA-020. The marine-derived bacterium, strain SNA-020, was isolated from a sediment sample collected at a depth of 1 meter near the prop roots of a mangrove tree in was added to adsorb organic products, and the culture and resin were shaken at 200 rpm for 2 h. The resin was filtered through cheesecloth, washed with deionized water, and eluted with methanol. The methanol soluble fraction was dried in vacuo to yield 8 g of extract.
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Ammosamide E. The extract (8 g) was partitioned with n-hexanes, CH 
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Ammosamide 
Attempts of chemical conversion of ammosamide B (4) to ammosamide G (9).
To a solution of 4 (1.0 mg, 0.0034 mmol) in methanol (0.1 mL) was added DIPEA (1.2 uL, 0.0068mmol) and 2-chloro-N-methylpyridinium iodide (1.0 mg, 0.0041 mmol). After stirring for five minutes at 25 ºC, 4-chloroaniline (0.65 mg, 0.0051 mmol) was added and the reaction was stirred for 24 hours. LC-MS analysis of the reaction showed no conversion of 4 to 9.
To a solution of 4 (0.5 mg, 0.0017 mmol) in neat POCl 3 (0.5 mL) was added 4-chloroaniline (0.3 mg, 0.0026 mmol) and stirred at 25 ºC for 1 hour. The reaction mixture (0.1mL) was analyzed by LC-MS and several ammosamide analogs were detected by LC-MS including: 9 (9% yield); 19 (23% yield); and 20 (39% yield).
Attempts of chemical conversion of ammosamide A (3) to ammosamide G (9).
To a solution of 3 (1.0 mg, 0.0032 mmol) in methanol (0.1 mL) was added DIPEA (1.1 uL, 0.0064mmol) and 2-chloro-N-methylpyridinium iodide (1.0 mg, 0.0041 mmol). After stirring for five minutes at 25 ºC, 4-chloroaniline (0.61 mg, 0.0048 mmol) was added and the reaction was stirred for 24 hours. LC-MS analysis showed trace production of 9 (<1%).
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To a solution of 3 (0.5 mg, 0.0016 mmol) in methanol (0.2 mL) was added silver tetrafluoroborate (1.6 mg, 0.0082 mmol), 4-chloroaniline (6.1 mg, 0.048 mmol) and NaHCO 3 (4.4 mg, 0.016 mmol). The reaction mixture was stirred at 25 o C for 2 h and concentrated. LC-MS analysis showed no conversion of 3 to 9.
Preparation of synthetic ammosamide C (5).
Synthetic ammosamide C was obtained according to the procedure of Hughes et al. 2 Briefly, to a solution of 3 (4.5 mg, 0.015 mmol) in anhydrous dioxane (2.0 mL) was added MeI (0.10 mL) via syringe. The mixture was heated at 80 °C overnight, allowed to cool, and concentrated to give the crude sulfonium salt. To a solution of the crude sulfonium salt in anhydrous MeOH (2.0 mL) was added NaBH 4 (20 mg). The mixture was stirred at room temperature for 2 h, diluted with a saturated NaHCO 3 solution (4 mL), and extracted with EtOAc (2 x 3 mL). The combined extracts were dried (Na 2 SO 4 ), filtered, and concentrated. well microtiter assay plates (Bio-one; Greiner, Inc.). After incubating the assay plates overnight under the growth conditions described above, purified compounds were dissolved and diluted in DMSO and subsequently added to each plate with final compound concentrations ranging from 40 µM to 1 nM and a final DMSO concentration of 0.5%. After an incubation of 96 h under growth conditions, Cell Titer GloTM reagent (Promega, Inc.) was added to each well and mixed. Plates were incubated for 10 min at room temperature and luminescence was determined for each well using an Envision multi-modal plate reader (Perkin Elmer, Inc.). Relative luminescence units were normalized to the untreated control wells (cells plus DMSO only).
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QR2 assay. Steady-state kinetic assays and QR2 IC 50 determination was accomplished using literature procedures. 3 The enzymatic activity of QR2 was determined using MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] and N-methyl dihydronicotinamide as substrates as previously described. Briefly, assays were run in a 96-well plate with a final assay volume of 200 µL, and the appearance of the reduced form of the MTT substrate, formazan, was monitored at 612 nm. The assay was performed at 23 °C using a Spectramax 340PC multimode microplate reader with Softmax Pro software. Each assay mixture contained 10 ng QR2, 25 µM N-methyl dihydronicotinamide, and 200 µM MTT reaction buffer containing 100 mM NaCl, 50 mM Tris, pH 7.5, and 0.1% TritonX-100. All reactions were initiated by the addition of QR2. Initial slopes of the reactions (ΔOD@612 nm/min) were measured and were used to calculate the initial rates of the reaction using a value of 11,300 M -1 cm -1 for the molar extinction coefficient of MTT. IC 50 values were determined using method assay as described above with the addition of inhibitor at varying concentrations 1nM to 10 µM (all data points acquired in triplicate). The average and standard deviations in the rate values were used to determine the IC 50
value by calculating the % inhibition at each inhibitor concentration versus the negative control with zero inhibitor. These data were plotted as the percent inhibition versus inhibitor concentration. All data were fit to the 
